A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Clinical trial NCT04945460 · COMPLETED

Trial details

NCT number: NCT04945460
Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2021-12-29
Primary completion: 2025-09-05
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.